简介:摘要目的探讨彩色多谱勒超声和经颅多谱勒对短暂性脑缺血发作的诊断价值。方法2016年7月至2017年7月期间我院共收治87例短暂性脑缺血发作患者,分别行彩色多普勒超声及经颅多普勒检查,并对检查结果进行分析。结果彩色多谱勒超声示24例短暂性脑缺血发作患者有颈动脉或(和)椎动脉狭窄或闭塞;55例有颈动脉或(和)椎动脉斑块,但不伴管腔狭窄。70例经颅多谱勒异常,表现频谱形态、流速、声音的异常。结论CT检查阳性率低,其他检查不能明确诊断,经颅多谱勒检查、颈动脉彩色多普勒超声检查对短暂性脑缺血发作诊断有非常重要的意义,但单独进行诊断时常特异性较差,易出现漏诊,采取2种方法联合应用,可显著提高诊断率,为临床诊治提供有力的指导。
简介:【摘要】目的:探讨有创呼吸机、无创呼吸机序贯治疗重症慢阻肺Ⅱ型呼吸衰竭的临床疗效。方法:选取我院自2021年3月-2023年5月收治的80例重症慢阻肺Ⅱ型呼吸衰竭的患者为观察对象,根据随机数字表法将其分为对照组和研究组各40例,其中对照组采用间歇性有创通气的方式进行治疗,研究组采用有创呼吸机、无创呼吸机序贯治疗的方式进行诊治,比较两组患者治疗的临床效果。结果:经过治疗后,对照组在脱机时间及住院时间均高于研究组,p<0.05;比较两组患者的血氧指标及体征变化,其对照组血氧指标中的变化明显低于研究组,且在体征变化的呼吸频率、心率指标均高于研究组,而在PH指标中低于研究组,p<0.05;对比两组患者的不良反应,对照组不良反应总发生率为25.50%,而研究组不良反应总发生率为5.00%,p<0.05。结论:有创、无创呼吸机序贯治疗对重症慢阻肺Ⅱ型呼吸衰竭的患者,不仅能使患者尽早脱机,还能缩短住院时间,且患者的血氧指标及体征都有效得到提高,临床不良反应显著降低,值得推广。
简介: [摘要 ] 目的 探讨有创呼吸机、无创呼吸机序贯治疗重症慢阻肺 II型呼吸衰竭的临床疗效。方法 方便择取该院 2018年 1月— 2020年 1月期间收治的 52例重症慢阻肺 II型呼吸衰竭患者为研究对象,按照前瞻性方式将 52例患者随机分为对照组和观察组,每组 26例。对照组给予间歇指令通气加压通气,观察组患者采用有创和无创序贯通气治疗。治疗结束后,评价两组患者的治疗效果。结果 观察组脱机时间( 4.2±1.20) d,对照组脱机时间( 5.8±1.40) d,差异有统计学意义( t=4.336 9, P<0.05)。两组患者治疗后血气指标各项值均较治疗前有显著改善,治疗后对照组患者各项指标稍优于观察组,但比较差异无统计学意义( P>0.05)。同时,从不良反应发生率上来看,观察组 7.69%显著低于对照组 19.23%,差异有统计学意义( χ2=5.716 4, P<0.05)。结论 针对重症慢阻肺 II型呼吸衰竭患者可给予有创和无创呼吸机序贯治疗的方式,改善患者血气指标,缩短脱机时间,患者耐受性好,提高治疗效果,值得推广。 [关键词 ] 有创呼吸机;无创呼吸机;序贯治疗;重症慢阻肺 II型呼吸衰竭 [Abstract] Objective To explore the clinical effect of sequential treatment of severe COPD type II respiratory failure with invasive ventilator and noninvasive ventilator. Methods 52 patients with severe COPD type II respiratory failure admitted in our hospital from January 2018 to January 2020 were selected as the study objects. According to the prospective way, 52 patients were randomly divided into control group and observation group, each group had 26 cases. The patients in the observation group were treated with invasive and noninvasive sequential ventilation. After the treatment, the therapeutic effect of the two groups was evaluated. Results the difference was statistically significant (t = 4.3369, P < 0.05). After treatment, the blood gas indexes of the two groups were significantly improved compared with those before treatment. After treatment, the indexes of the control group were slightly better than those of the observation group, but the difference was not statistically significant (P > 0.05). At the same time, in terms of the incidence of adverse reactions, 7.69% in the observation group was significantly lower than 19.23% in the control group, the difference was statistically significant (χ 2 = 5.7164, P < 0.05). Conclusion for the patients with severe COPD type II respiratory failure, the sequential treatment of invasive and non-invasive ventilator can be given to improve the blood gas index of patients, shorten the time of weaning, improve the tolerance of patients, and improve the treatment effect, which is worth popularizing.